Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Treasury Shares (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Treasury Shares for 10 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 79.06% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Dec 2025, up 79.06%, and an annual FY2025 reading of $1.5 million, up 79.06% over the prior year.
  • Treasury Shares was $1.5 million for Q4 2025 at Wave Life Sciences, down from $1.8 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.9 million in Q4 2021 and bottomed at $614449.0 in Q1 2023.
  • Average Treasury Shares over 5 years is $1.1 million, with a median of $832043.0 recorded in 2024.
  • The sharpest move saw Treasury Shares tumbled 50.18% in 2022, then surged 181.15% in 2025.
  • Year by year, Treasury Shares stood at $1.9 million in 2021, then crashed by 50.18% to $934342.0 in 2022, then plummeted by 31.76% to $637557.0 in 2023, then soared by 30.5% to $832043.0 in 2024, then soared by 79.06% to $1.5 million in 2025.
  • Business Quant data shows Treasury Shares for WVE at $1.5 million in Q4 2025, $1.8 million in Q3 2025, and $1.8 million in Q2 2025.